Recent News

By Category: Agents & Toxins

6 suspected cases of Ebola fever reported in DR Congo

(GlobalTimes) Six suspected cases of Ebola fever were reported between May 1 and 12 in the Mongo health zone in Orientale province in the northeast of the Democratic Republic of Congo (DR Congo). The revelations were made on Wednesday in a statement released in Kinshasa by the United Nations Coordination for Humanitarian Affairs (OCHA). “Through  Read More »

MRSA study slashes deadly infections in sickest hospital patients

(CDC) Using germ-killing soap and ointment on all intensive-care unit (ICU) patients can reduce bloodstream infections by up to 44 percent and significantly reduce the presence of methicillin-resistant Staphylococcus aureus (MRSA) in ICUs. A new Department of Health and Human Services-funded study released today tested three MRSA prevention strategies and found that using germ-killing soap  Read More »

Science Academies Issue ‘G-Science’ Statements to Call World Leaders’ Attention to Global Challenges

(NationalAcademies) Science academies from around the globe issued joint statements today to call world leaders’ attention to the role science, technology, and innovation can play in the pursuit of sustainable development, and to raise their awareness of the emerging threat of drug resistance in infectious agents including tuberculosis. The “G-Science” statements are intended to inform  Read More »

Genetic engineering alters mosquitoes’ sense of smell

(EurekAlert) In one of the first successful attempts at genetically engineering mosquitoes, Howard Hughes Medical Institute (HHMI) researchers have altered the way the insects respond to odors, including the smell of humans and the insect repellant DEET. The research not only demonstrates that mosquitoes can be genetically manipulated using the latest research techniques, but paves  Read More »

Experimental Drug Could Treat Child Bioterrorism Victims

(GlobalSecurityNewswire) The United States on Friday announced a $17.7 million push to secure federal licensure of an experimental antibiotic officials believe could treat young victims of anthrax or tularemia bacteria. Announcement of the two-year research and development deal with a North Carolina pharmaceutical firm came weeks after congressional investigators warned that minors could have only  Read More »